BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26269936)

  • 1. Effectiveness of Laser Application for Periodontal Surgical Therapy: Systematic Review and Meta-Analysis.
    Behdin S; Monje A; Lin GH; Edwards B; Othman A; Wang HL
    J Periodontol; 2015 Dec; 86(12):1352-63. PubMed ID: 26269936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guided tissue regeneration for periodontal infra-bony defects.
    Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.
    Graziani F; Gennai S; Cei S; Ducci F; Discepoli N; Carmignani A; Tonetti M
    J Clin Periodontol; 2014 Apr; 41(4):377-86. PubMed ID: 24329867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guided tissue regeneration for periodontal infra-bony defects.
    Needleman IG; Giedrys-Leeper E; Tucker RJ; Worthington HV
    Cochrane Database Syst Rev; 2001; (2):CD001724. PubMed ID: 11406001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative surgery versus access flap for the treatment of intra-bony periodontal defects: A systematic review and meta-analysis.
    Nibali L; Koidou VP; Nieri M; Barbato L; Pagliaro U; Cairo F
    J Clin Periodontol; 2020 Jul; 47 Suppl 22():320-351. PubMed ID: 31860134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
    Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
    J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
    J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.
    Li W; Xiao L; Hu J
    J Am Dent Assoc; 2012 Sep; 143(9):e46-56. PubMed ID: 22942155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enamel matrix derivative for periodontal tissue regeneration in treatment of intrabony defects: a Cochrane systematic review.
    Esposito M; Coulthard P; Thomsen P; Worthington HV
    J Dent Educ; 2004 Aug; 68(8):834-44. PubMed ID: 15286106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R; Deo V
    Int J Periodontics Restorative Dent; 2013; 33(2):e58-64. PubMed ID: 23484181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2003; (2):CD003875. PubMed ID: 12804493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.